Interleukin 28B Genotyping as a Predictor Marker for Responsiveness of HCV Patients to Therapy
Journal: International Journal of Science and Research (IJSR) (Vol.6, No. 4)Publication Date: 2017-04-05
Authors : Laith Jabbar Abdulhassan; Ahmed Sahib Abdulamir; Nawal Mehdi Alkhalidi; Safaa Abdulkareem Alwaysi;
Page : 1033-1039
Keywords : HCV; Interleukin 28B;
Abstract
Single nucleotide polymorphism (SNPs) in the IL-28B gene, namely rs12979860 and rs8099917 could predict response to pegylated interferon and ribavirin therapy in hepatitis C virus patients. The current study investigated 50 Iraqi HCV infected patients with HCV genotype1 and 4 compared to 40 healthy individuals. For rs12979860, the homozygous C allele genotype (CC) showed high rate of viral response (75 %) compared to other genotypes CT and TT (66.6 %, 45, 4 % respectively). For rs8099917, interestingly the homozygous G allele genotype (GG) showed no response (0 %) while other genotypes TG and TT showed (58.6 %, 63.1 %) respectively. Our findings highlight an association of IL28B rs12979860 and rs8099917 genotypes, and HCV genotyping which is useful in clinical practice for patients risk stratification based on interferon responsiveness.
Other Latest Articles
- Aircraft Target Identification by Null Polarization Based Feature Set
- Constructing of Accountability Based Values of Sulapa Appa Wisdom
- Circulating 25-Hydroxyvitamin D and Insulin Resistance in Patients with Coronary Heart Disease
- Design and Analysis of Picking Mechanism of Shuttle Loom
- Full Potential Linearized Augmented Plane Wave Calculations of Structural and Optoelectronic Properties of KCdF3
Last modified: 2021-06-30 18:32:29